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ing author. Tel.: +34 93
ess: jbarbera@clinic.ubSummary Chronic obstructive pulmonary disease is associated with systemic
effects including reduced body weight, oxidative stress and altered circulating TNFa
levels. The present study was aimed to investigate whether chronic exposure to
cigarette smoke induces these systemic changes in a guinea pig model.
Seven animals/group were exposed to the smoke of seven cigarettes/day, 5 days/
week, during 2, 4 and 6 months (chronic exposure). Three animals/group were
sacrificed immediately, 3 h or 24 h after exposure to seven cigarettes (acute
exposure). Chronically smoke-exposed animals exhibited lower body weight gain,
starting at 5th week, and goblet cell metaplasia in small bronchioles. At 6 months
there was a trend for increased plasma and lung tissue TNFa levels. No changes,
neither in skeletal muscle glutathione (GSH) nor in plasma lipid peroxidation, were
observed at any time point after chronic exposure. However, skeletal muscle GSH
decreased and plasma lipid peroxidation increased immediately after acute smoke
exposure, equaling control levels thereafter.
We conclude that cigarette smoke exposure in the guinea pig induces a transient
and repeated oxidative effect, which might result in impaired systemic metabolism
and consequent failure of smoke-exposed animals to gain weight. The effects of
cigarette smoke on body weight antecede and appear to be independent from the
alterations produced in small airways.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Chronic obstructive pulmonary disease (COPD) is
characterized by an inappropriate/excessive in-
flammatory response of the lung to respiratory
pollutants, mainly cigarette smoking.1 In addition
to the typical pulmonary pathologic changes of
COPD, several effects occurring outside the lung
have been described, the so-called systemic effects
of the disease.2 There is increasing awareness that
these systemic effects are clinically relevant and
may contribute to a better understanding and
management of the disease.
Recent studies have clearly shown that COPD is
associated not only with an abnormal inflammatory
response in the lung parenchyma, but also with
evidence of systemic inflammation, namely sys-
temic oxidative stress, activation of circulating
inflammatory cells and increased levels of proin-
flammatory cytokines.3
The level of lipid peroxidation in plasma, as an
index of oxidative stress, is significantly increased
by both cigarette smoking and COPD, the latter
being particularly significant during exacerbation
episodes.4 Numerous studies have reported in-
creased levels of circulating cytokines and acute
reactants in the peripheral circulation of patients
with COPD, particularly, increased concentrations
of TNFa, its receptors (TNFR-55 and TNFR-75), IL-6,
IL-8, C-reactive protein, lipopolysaccharide-bind-
ing protein and FAS and Fas ligand.5–8 It is
interesting to note that chronic elevation of TNFa
is associated with muscle wasting that can be
ameliorated with antibodies against TNF.9,10
Cigarette smoking alone can cause, in the
absence of COPD, significant extrapulmonary dis-
eases (e.g. coronary artery disease). Young smokers
and even passive smokers may show endothelial
dysfunction of the systemic vessels11,12 and sys-
temic oxidative stress.13 Oxidative stress causes
muscle fatigue14 and facilitates proteolysis.15,16
This may be particularly relevant in COPD since
the regulation of glutathione (GSH), the most
important intracellular antioxidant,17 is abnormal
in the skeletal muscle of COPD patients.18 Indeed,
an optimal GSH content is necessary to ensure the
appropriate redox environment needed for myo-
genesis.19
Cigarette smoking has the potential to contribute
to systemic effects of COPD. Nevertheless,
although it is accepted that cigarette smoking is
the main risk factor for COPD,1 much less attention
has been paid to its potential effects on skeletal
muscle structure and function. There is a wide
variety of animal models of cigarette smoke-
induced lung disease that have been used toinvestigate different aspects of COPD.20 However,
little is known about the potential systemic effects
of cigarette smoking in these animal models.
Guinea pigs chronically exposed to cigarette
smoke develop pulmonary histological changes
(emphysema, goblet cell metaplasia in small
bronchioles, vascular remodeling) and functional
abnormalities (increased lung volumes, gas trap-
ping, pulmonary hypertension)21 that are similar to
those seen in humans with COPD. Accordingly, we
used the guinea pig model to investigate whether
chronic or acute exposure to cigarette smoke
induces systemic changes, such as increased plasma
levels of TNFa and oxidative stress, both in plasma
and skeletal muscle.Materials and methods
Materials and reagents
GSH and GSSG reductase were purchased from
Sigma (Madrid, Spain). 20-70-Dichlorofluorescein
was purchased from Molecular Probes (Eugene,
OR, USA).
Experimental protocol
Chronic exposure
Groups of seven male Hartley guinea pigs, initially
weighting 300 g, were exposed to the smoke of
seven commercial cigarettes (11mg tar, 0.8mg
nicotine per cigarette) each day, 5 days per week,
for periods of 2, 4 and 6 months using a nose-only
inhalation system.21 Control animals (Ctrl) followed
the same procedures except cigarette smoke
exposure. Diet was given ad libitum and water
was supplemented with Vit C (1 g/L) (Roche Farma
S.A., Madrid, Spain).
At the end of each period the animals were
anesthetized 24 h after the last session of smoke
exposure. Whole blood was obtained from carotid
artery and collected in tubes with EDTA. After
centrifugation at 1200g 10min, plasma samples
were immediately stored at 70 1C until analyzed.
Skeletal muscle samples from the gastrocnemius
muscle and lung samples were obtained. Fresh
muscle (2 g) was used to isolate mitochondria. The
remaining fresh muscle tissue and lung samples
were immediately placed in liquid N2 and stored at
70 1C until analyzed.
Acute exposure
Three male Hartley guinea pigs per group were
exposed to the smoke of seven commercial
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or 24 h after exposure. Control animals (Ctrl)
followed the same procedures except cigarette
smoke exposure.
Skeletal muscle and lung tissue samples were
processed and analyzed as described above. Whole
blood was drawn from the carotid artery. Carbox-
yhemoglobin concentration was determined using a
gas analyzer (CIBA-Corning 860, CIBA-Corning Diag-
nostics Corporation, Medfield, MA, USA).Mitochondria isolation and GSH determination
Mitochondria skeletal muscle was obtained by a
modification of the Rustin method.22 Briefly, ap-
proximately 2 g of muscle was homogenized in
medium containing 20mM Tris pH ¼ 7.2, 0.25M
sucrose, 40mM KCl, 2mM EGTA and 1mg/ml BSA
(medium A) and centrifuged twice at 500g for
8min. The supernatants of both centrifugations
were further centrifuged at 12000g for 8min. The
supernatant was discarded and the pellet was
centrifuged again in medium A plus 5% Percoll.
The resulting pellet containing the mitochondrial
fraction was resuspended in 0.5ml homogenization
medium. Mitochondria purity was confirmed by
specific activity of succinate dehydrogenase in the
final mitochondrial fraction with respect to that of
the homogenate. Homogenate and mitochondria
samples were treated with 5% trichloroacetic acid,
the mixture was centrifuged to discard precipitated
protein, and the content of GSH and GSSG was
analyzed by HPLC.23Reactive oxygen species determination
Hydrogen and other organic peroxides were mon-
itored spectrofluorimetrically in isolated mitochondria
samples, using chlorometyl-20-70-dichlorodihydrofluor-
escein diacetate (2mmol/L) determining the fluores-
cence of 20-70-dichlorofluorescein (DCF) as described
previously in detail.23 Relative fluorescence units
were normalized per mg of cellular protein.Lipid peroxidation
Lipid peroxidation, as malondialdehyde (MDA) and
4-hydroxinonenal (4-HNE), was analyzed in frozen
plasma samples spectrophotometrically using a
commercial kit (Byoxytech. LPO-586, Oxys Re-
search, Portland, OR, USA).TNFa levels determination
TNFa levels were determined in plasma and lung
homogenates samples by ELISA (BD Biosciences, San
Jose, CA, USA).Morphometric studies in lung tissue
Formalin fixed paraffin-embedded lung tissue sec-
tions were cut and stained with H&E and alcian blue
to evaluate the number of secretory cells in small
airways as an index of bronchial damage induced by
cigarette smoke.24 The number of secretory cells in
the airway epithelium of small noncartilagenous
bronchioles was counted and expressed as the
number of cells per mm of epithelial length.
Nutritional status
Plasma nutritional profile was assessed to check for
potential malnourishment in smoke-exposed ani-
mals. Cholesterol was determined with a Bayer
reagent (B01-4124-01), triglycerides with an Olym-
pus System reagent (66003), and total proteins by a
modified Biuret method (OSR6232), and albumin
with a Bayer bromocresol green (B01-4121-01). All
parameters were determined spectrophotometri-
cally by an autoanalyzer ADVIA 1650 (Bayer Tarry-
town, New York, USA).
Statistics
All data were expressed as mean7SD. Comparisons
between groups were performed using an analysis
of variance (ANOVA) or the Kruskal–Wallis test,
when appropriate. Comparisons were carried out
using the Student’s test. Correlations between
variables were analyzed with Pearson’s coefficient.
Probability values lower than 0.05 were considered
as significant.Results
To validate the method of smoke exposure used in
this study, blood carboxyhemoglobin (HbCO) con-
centration was measured in guinea pigs acutely
exposed to cigarette smoke. The concentration of
HbCO in arterial blood, measured immediately
after exposing the animals to the smoke of seven
cigarettes, was 1371%.
Effects of long-term exposure to cigarette
smoke
Skeletal muscle and plasma oxidative stress
GSH concentration in skeletal muscle was measured
to evaluate the potential systemic impact of
cigarette smoke. The levels of total GSH (GSH plus
GSSG) in skeletal muscle homogenate and mito-
chondria after 2, 4 and 6 months of cigarette smoke
exposure, are shown in Fig. 1(A and B). Although no
significant differences in GSH levels were observed
between the groups at the different exposure
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mitochondria (Fig. 1B) after 2 months of cigarette
smoke exposure compared with the control group
(p ¼ 0:07).
Because cigarette smoke is associated with an
overproduction of reactive oxygen species (ROS),
we determined ROS generation by the skeletal
muscle mitochondria, as well as levels of MDA plus
4-HNE in plasma as end products of oxidative stress.
No evidence for increased ROS was detected at 2
and 4 months of exposure (data not shown). At 6
months there was a trend to increase ROS genera-
tion in mitochondria of smoke-exposed animals (1.5
fold increase in smokers vs. controls, p ¼ 0:08).
MDA+4-HNE plasma levels were not significantly
different in control and smoke-exposed animals at
any time of exposure (Fig. 1C). In agreement with
the results of plasma lipid peroxidation and skeletal
muscle GSH levels, there was no evidence of an
increased systemic oxidative stress.Figure 2 Rate of body weight gain over time. Smoke-
exposed guinea pigs (open symbols), initially weighting
300 g, showed a reduced rate of weight gain, beginning at
the 5th week of exposure until the final of the study, as
compared with control guinea pigs (closed symbols).
Symbols show mean7SD. n ¼ denotes the total number
of animals studied until that time point. *po0:05
compared with smoke-exposed group.Body weight
The evolution of body weight of control and smoke-
exposed animals over time is shown in Fig. 2. The
rate of body weight gain in guinea pigs exposed
to cigarette smoke was lower than in control
animals. Difference in weight gain started at week
5 and persisted thereafter. Smoke-exposed animals
weighed approximately 100 g less than controls atFigure 1 Oxidative stress in skeletal muscle and plasma. Tota
lipid peroxidation were determined as markers of systemic oxi
exposed (dashed bars) and control (filled bars) guinea pigs. N
muscle homogenate (A) and isolated mitochondria (B) and p
mean7SD.every time point of the study. To discard malnour-
ishment as a potential cause of reduced body
weight gain we measured parameters of nutritional
profile in plasma (Table 1). No differences in thel GSH content (GSH+GSSG) in skeletal muscle and plasma
dative stress, after 2, 4, and 6 months in cigarette smoke-
o differences were shown in GSH levels in total skeletal
lasma levels of MDA+4-HNE (C). Results are expressed as
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Table 1 Nutritional profile.
2 months 4 months 6 months
Ctrl Smkr Ctrl Smkr Ctrl Smkr
Cholesterol
(mg/dl)
38714 42710 37712 3873 49716 45710
Triglicerides
(mg/dl)
69744 62727 74738 80730 1697106 183796
Total proteins
(g/l)
4074 4472 43712 4472 5073 4874
Albumin (g/l) 2772 2971 2877 2971 3173 3173
Definition of abbreviations: Ctrl: control; Smkr: cigarette smoke-exposed.
Figure 3 Goblet cell metaplasia in small airways.
(A) Number of secretory cells in the airway epithelium
after 2, 4 and 6 months in smoke-exposed (dashed bars)
and control (filled bars) guinea pigs. (B) Transverse
sections of small bronchioles stained with alcian blue
from control (left panel) and smoked-exposed (right
panel) guinea pigs. Note the increased number of goblet
cells (light blue stained cells) in the epithelial surface of
smoke-exposed animals. Internal scale bar ¼ 50 mm.
*po0:05 compared with control animals.
E. Ardite et al.1190levels of cholesterol, total protein content and
albumin were observed in smoke-exposed animals
as compared to control ones, at any time point.
Triglycerides increased after 6 months of exposure
at the same level both in control and smoke-
exposed animals.
Histological changes in the airways
To evaluate the deleterious effect of chronic
cigarette smoke exposure on the airways we
evaluated the extent of goblet cell metaplasia in
small noncartilaginous bronchioles (Fig. 3). There
was a significant increase in the number of goblet
cells at 4 and 6 months in smoke-exposed animals,
confirming airway epithelial damage induced by
cigarette smoke (Fig. 3A). Interestingly, airway
epithelial damage was apparent much later than
the reduction of body weight gain (Figs. 2 and 3).
Inflammatory response
Cigarette smoke may induce an inflammatory
response in the lung with enhanced release of TNFa.
To evaluate this response in our experimental
model, we determined TNFa production both in
plasma and whole-lung tissue. At 2 and 4 months of
exposure no TNFa release was detected (detection
limit with the ELISA kit is 1–2pg/ml). After 6 months
of exposure there were detectable TNFa levels
(Fig. 4). Whole-lung TNFa content in smoke-exposed
and control animals was similar (Fig. 4A). Interest-
ingly there was a trend to increase TNFa levels in
plasma of smoke-exposed animals compared with
the control group (p ¼ 0:06), likely suggesting a
systemic inflammatory process (Fig. 4B).
Effects of acute exposure to cigarette smoke
Skeletal muscle, lung and plasma oxidative stress
Having shown that cigarette smoke did not induce
significant chronic oxidative stress neither in thelung nor in the plasma of guinea pigs, we tested the
hypothesis that cigarette smoke might induce
oxidative stress acutely.
Compared with control animals, exposure of
guinea pigs to seven cigarettes caused a significant
reduction of GSH levels in skeletal muscle, in
both total homogenate and isolated mitochondria
(Fig. 5A and B, respectively), which was apparent
immediately after finishing the cigarette smoke
exposure. However, levels measured 3 and 24 h
after finishing the smoke exposure were similar to
those measured in controls. Lung homogenate GSH
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animals, as compared to controls (Fig. 5C).
In agreement with the reduction of GSH content
in skeletal muscle immediately after cigaretteFigure 5 Oxidative stress after acute cigarette smoke-expo
bars) guinea pigs. Skeletal muscle GSH content in total ho
immediately after cigarette smoke exposure (*po0:05). No d
24 h after smoke exposure. No differences were shown in GSH
exposure (C). Plasma lipid peroxidation, measured as MDA
cigarette smoke exposure (*po0:05) returning to control val
Figure 4 TNFa levels after 6 months of exposure. TNFa
content in whole-lung homogenate (A) and plasma (B) of
control (Ctrl) and smoke-exposed guinea pigs (Smkr).
There was a trend for increased TNFa levels in plasma of
smoke-exposed guinea pigs (p ¼ 0:06).smoke exposure, lipid peroxidation in plasma
increased significantly. By contrast, at 3 h and 24 h
post-exposure MDA plus 4-HNE levels were compar-
able to paired controls (Fig. 5D).
Inflammatory process
Release of TNFa after acute cigarette smoke
exposure was measured both in plasma and
whole-lung tissue. No TNFa release could be
detected in plasma at any time point. In lung
tissue, TNFa could be detected, although there was
no difference between controls and cigarette
smoke-exposed animals. TNFa levels at all time
points averaged 21.973 pg/mg prot in controls
and 20.871.5 pg/mg prot in smoke-exposed guinea
pigs.Discussion
There is consistent evidence indicating that COPD
has an important systemic component.2 Our study
examined the systemic manifestations of cigarette
smoking after long-term and acute exposure in a
guinea pig model, in terms of systemic oxidative
stress measured both in plasma and skeletal
muscle. Although the amount of smoke that the
guinea pigs inhaled in this study differs from that of
smokers, the current model has been widely used
to study the effects of cigarette smoke on lung andsure in control (filled bars) and smoke-exposed (dashed
mogenate (A) and isoalted mitochondria (B) decreased
ifferences were shown in measurements performed 3 and
levels of whole-lung homogenate at any time after smoke
levels plus 4-HNE, increased immediately after acute
ues at 3 and 24 h post-exposure (D).
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the first study that has evaluated the level of
oxidative stress in skeletal muscle in rodents
exposed to cigarette smoke, since other studies
have focused their investigation in local pulmonary,
hepatic, renal cardiac or bladder muscle,25,26 but
not in skeletal muscle.
Our data reveal no significant evidence of
systemic oxidative stress after long-term exposure
to cigarette smoke, since neither the levels of MDA
plus 4-HNE, as signs of plasma lipid peroxidation,
nor the levels of total GSH, both in homogenate and
mitochondria of skeletal muscle, underwent sig-
nificant changes as compared to control values
after 2, 4 and 6 months of exposure (Fig. 1).
Cigarette smoke is a complex mixture of over
4700 identified constituents4 that includes numer-
ous reactive substances such as a large quantity of
reactive aldehydes26 and free radical species, not
only oxygen free radicals but also nitrogen spe-
cies.27 All of these compounds are capable to react
with protein thiols and with the main nonprotein
thiol such as GSH. Indeed, recent observations
reported that cigarette smoke depletes GSH in the
lining fluid of the respiratory tract due to conjuga-
tion of GSH with acrolein and crotonaldehyde.28 In
contrast to these findings in respiratory tissue our
data show that chronic cigarette smoke exposure
did not result in significant oxidative stress in
plasma or skeletal muscle. However, cigarette
smoke caused oxidative stress acutely in extra-
pulmonary tissues, as evidenced by the increase in
lipid peroxidation in plasma and the reduction of
GSH content in skeletal muscle. The different
outcome between chronic and acute exposure to
cigarette smoke shown here in skeletal muscle may
be indicative of an adaptive response. For instance,
acute smoking has been shown to deplete GSH in
the lung, whereas chronic smoking increased GSH
levels in epithelial lining fluid.29
In our study pulmonary GSH was not affected by
smoke exposure at any time point, indicating that
there was a significant store of GSH in this organ
that did not interact with cigarette smoke. This
result could be explained by differences in the
efficiencies of antioxidant systems and repair
enzymes among tissues. Indeed, there is a larger
amount of GSH in the lung (16 nmols/mg prot)
respect to skeletal muscle (7 nmols/mg prot), so
that a reduced tissue response would be expected.
Our findings are in agreement with those of
Bilimora et al.25 that revealed that exposure to
cigarette smoke at a dose about 4 times greater
than that used in our study, resulted in only 22%
depletion of pulmonary GSH immediately after
smoke exposure, being completely replaced 3 hafter treatment. Studies in rats have revealed that
GSH lung levels decreased immediately30,31 and 1 h
after smoke exposure returning to normal levels
after 2–6 h of exposure.32 This indicates that there
are differences between species and cigarette
doses, but even at exceptionally high levels of
exposure, there is a significant store of GSH in lung
tissue that does not interact with cigarette smoke.
Interestingly, the acute study shows a systemic
impact of cigarette smoke by a mechanism that
questions the idea that cigarette smoke intermedi-
ates should elicit a local action on pulmonary tissue
prior to exert any systemic action.25 Importantly,
acute smoke exposure did result in tissue damage,
as suggested by increased products of lipid perox-
idation and decreased skeletal muscle GSH levels,
both in homogenate and mitochondria, immedi-
ately after smoke exposure. Membrane lipid per-
oxidation is a consequence of oxidative stress. The
aldehyde 4-hydroxy-2-nonenal (4-HNE) is a stable
end product of lipid peroxidation, which is highly
reactive and diffusible and can cause oxidative
damage in DNA, lipids and proteins in tissues far
from the original site. The delicate balance that
exists between the toxicity of oxidants and the
protective effects of intra- and extracellular anti-
oxidant defense systems is critical for the main-
tenance of normal skeletal muscle function.
Inherent to its function, skeletal muscle is con-
tinuously exposed to fluctuations in its redox
environment, as during exercise when the mito-
chondrial respiratory chain increases ROS produc-
tion.33 In addition, proteins of the contractile
apparatus itself may be oxidized by ROS, which
may impair force development and muscle con-
tractility, and also compromise muscle function
indirectly by inducing muscle atrophy.34 Further-
more, oxidative stress may also result in apoptosis
of skeletal myocytes35 thereby contributing to
muscle atrophy.
In agreement with the acute results, a reduction
in body weight gain was observed in smoke-exposed
animals starting at the 5th week after initiating
smoke exposure, which was maintained after 6
months of cigarette smoking. This observation is
consistent with a general alteration of body
composition induced by cigarette smoke products.
It is interesting to note that reduction of body
weight gain was apparent much earlier than the
histological changes in the airways, likely suggest-
ing that changes in skeletal muscle may be
independent from changes occurring in the lung.
Since cigarette smoke might alter food intake, we
investigated the nutritional profile to evaluate
malnourishment as a potential cause of reduced
body weight gain. The lack of changes in total
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albumin indicates that the loss of approximately
100 g of body weight in smoke-exposed animals was
not due to inanition. In this respect, it should be
noted that studies on the nutritional abnormalities
associated with COPD suggest that these patients
may suffer from cachexia rather than malnourish-
ment. Indeed, in COPD the caloric intake is normal
or even greater than normal, not lower as in
malnourishment, and the response to nutritional
support is often poor.36 Such observations are
consistent with our findings in the guinea pig model
and suggest that reduced weight gain might result
from a toxic effect of cigarette smoke exposure
rather than a consequence of reduced food intake.
Cigarette smoke, due to its high concentration of
free radicals,37 may cause transient and repeated
oxidative imbalances that might result in impaired
muscle metabolism and promote muscle atrophy,
which may become apparent in terms of body
weight after several weeks of smoke exposure.
Cigarette smoking can also elicit complex phy-
siological and pathological responses including
inflammatory-immune system activation. There-
fore, oxidative damage of cell components can be
derived not only from a direct reaction with
reactive substances contained in cigarette smoke,
but also from smoke-induced secondary events such
as activation and infiltration of phagocytes into the
lung. Inflammatory lung cells release inflammatory
cytokines, such as TNFa, IL-6, IL-1b, that may reach
the systemic circulation and contribute to the
activation of inflammatory cells.38 In our study,
we did not find TNFa release in lung tissue, which is
consistent with a lack of lung damage. Only, after 6
months of cigarette exposure we observed a trend
to increase TNFa levels, both in plasma and lung
tissue, likely suggesting lung inflammation, which is
consistent with the presence of goblet cell meta-
plasia in small airways.
In conclusion, cigarette smoke exposure in the
guinea pig induces a transient and repeated
oxidative effect, which might result in impaired
systemic metabolism and consequent failure of
smoke-exposed animals to gain weight. This effect
antecedes and appears to be independent from the
characteristic changes occurring in the lung.Acknowledgements
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